260 related articles for article (PubMed ID: 23122795)
1. Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide.
Chen HH; Glockner JF; Schirger JA; Cataliotti A; Redfield MM; Burnett JC
J Am Coll Cardiol; 2012 Dec; 60(22):2305-12. PubMed ID: 23122795
[TBL] [Abstract][Full Text] [Related]
2. Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Pre-Clinical Diastolic Dysfunction (Stage B Heart Failure).
Wan SH; McKie PM; Schirger JA; Slusser JP; Hodge DO; Redfield MM; Burnett JC; Chen HH
JACC Heart Fail; 2016 Jul; 4(7):539-547. PubMed ID: 26874387
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Horton DP; Burnett JC
J Card Fail; 2004 Apr; 10(2):115-9. PubMed ID: 15101022
[TBL] [Abstract][Full Text] [Related]
4. Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure.
McKie PM; Schirger JA; Benike SL; Harstad LK; Slusser JP; Hodge DO; Redfield MM; Burnett JC; Chen HH
Eur J Heart Fail; 2016 Apr; 18(4):433-41. PubMed ID: 26806605
[TBL] [Abstract][Full Text] [Related]
5. Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction.
Wan SH; McKie PM; Slusser JP; Burnett JC; Hodge DO; Chen HH
Physiol Rep; 2021 Aug; 9(16):e14974. PubMed ID: 34405565
[TBL] [Abstract][Full Text] [Related]
6. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.
Guazzi M; Vicenzi M; Arena R; Guazzi MD
Circ Heart Fail; 2011 Jan; 4(1):8-17. PubMed ID: 21036891
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
[TBL] [Abstract][Full Text] [Related]
8. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
Chen HH; Lainchbury JG; Harty GJ; Burnett JC
Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous administration of brain natriuretic peptide in experimental heart failure.
Chen HH; Grantham JA; Schirger JA; Jougasaki M; Redfield MM; Burnett JC
J Am Coll Cardiol; 2000 Nov; 36(5):1706-12. PubMed ID: 11079680
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of B-type natriuretic peptide for the preservation of left ventricular function after anterior myocardial infarction.
Sangaralingham SJ; Burnett JC; McKie PM; Schirger JA; Chen HH
J Card Fail; 2013 Aug; 19(8):533-9. PubMed ID: 23910581
[TBL] [Abstract][Full Text] [Related]
11. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP.
Wan SH; Torres-Courchoud I; McKie PM; Slusser JP; Redfield MM; Burnett JC; Hodge DO; Chen HH
JACC Basic Transl Sci; 2019 Dec; 4(8):962-972. PubMed ID: 31909303
[TBL] [Abstract][Full Text] [Related]
13. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
Palazzuoli A; Silverberg DS; Iovine F; Calabrò A; Campagna MS; Gallotta M; Nuti R
Am Heart J; 2007 Oct; 154(4):645.e9-15. PubMed ID: 17892986
[TBL] [Abstract][Full Text] [Related]
14. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide.
Watanabe T; Iwai-Takano M; Oikawa M; Yamaki T; Yaoita H; Maruyama Y
J Am Soc Echocardiogr; 2008 Jun; 21(6):689-96. PubMed ID: 17904810
[TBL] [Abstract][Full Text] [Related]
15. Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury.
George I; Morrow B; Xu K; Yi GH; Holmes J; Wu EX; Li Z; Protter AA; Oz MC; Wang J
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H708-17. PubMed ID: 19525373
[TBL] [Abstract][Full Text] [Related]
16. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
17. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy.
Kainuma S; Taniguchi K; Toda K; Shudo Y; Takeda K; Funatsu T; Miyagawa S; Kondoh H; Nishi H; Yoshikawa Y; Fukushima S; Hamada S; Kubo K; Daimon T; Sawa Y
J Cardiol; 2015 Oct; 66(4):279-85. PubMed ID: 25851471
[TBL] [Abstract][Full Text] [Related]
19. Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study.
Chen HH; Martin FL; Gibbons RJ; Schirger JA; Wright RS; Schears RM; Redfield MM; Simari RD; Lerman A; Cataliotti A; Burnett JC
Heart; 2009 Aug; 95(16):1315-9. PubMed ID: 19447837
[TBL] [Abstract][Full Text] [Related]
20. Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients.
Simioniuc A; Carluccio E; Ghio S; Rossi A; Biagioli P; Reboldi G; Galeotti GG; Lu F; Zara C; Whalley G; Temporelli PL; Dini FL;
Int J Cardiol; 2016 Dec; 224():416-423. PubMed ID: 27690339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
